Published in Pharm Res on February 01, 1994
Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A (1993) 3.37
Sites and thermodynamic quantities associated with proton and metal ion interaction with ribonucleic acid, deoxyribonucleic acid, and their constituent bases, nucleosides, and nucleotides. Chem Rev (1971) 2.30
Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res (1998) 1.79
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci (1997) 1.79
Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol (1994) 1.46
Microemulsions for topical delivery of estradiol. Int J Pharm (2003) 1.39
Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J Pharm Sci (2001) 1.31
Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim Biophys Acta (1999) 1.31
Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharm Res (1995) 1.29
Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm (2000) 1.24
Thermodynamic pK, delta H-o, delta S-o, and delta Cp-o values for proton dissociation from several purines and their nucleosides in aqueous solution. Biochemistry (1970) 1.24
Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci (2001) 1.24
Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol (2001) 1.20
Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol (1997) 1.19
Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release (1999) 1.18
Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res (1994) 1.13
{beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. J Pharmacol Exp Ther (2004) 1.11
Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J Biol Chem (2001) 1.08
Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J Pharm Sci (1994) 1.05
Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J Pharmacol Exp Ther (2001) 1.04
Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci (1995) 1.03
Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. Pharm Res (2001) 1.00
Starch acetates--multifunctional direct compression excipients. Pharm Res (2000) 0.98
Time-dependent densification behaviour of cyclodextrins. J Pharm Pharmacol (1996) 0.98
Thermodynamics of proton dissociation in dilute aqueous solution. 8. pK, change in heat content, and change in entropy values for proton ionization from several pyrimidines and their nucleosides at 25 degrees. J Phys Chem (1967) 0.98
Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. Biochim Biophys Acta (1996) 0.98
Thermodynamics of proton dissociation in dilute aqueous solution. V. An entropy titration study of adenosine, pentoses, hexoses, and related compounds. J Am Chem Soc (1966) 0.98
Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration. Pharm Res (1998) 0.97
P-glycoprotein efflux pump expression and activity in Calu-3 cells. J Pharm Sci (2001) 0.96
Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. Eur J Pharm Sci (2006) 0.96
Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs. Peptides (1993) 0.96
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci (1999) 0.94
Nitric oxide and blood-brain barrier integrity. Antioxid Redox Signal (2001) 0.94
Dexmedetomidine-induced ocular hypotension in rabbits with normal or elevated intraocular pressures. Invest Ophthalmol Vis Sci (1992) 0.94
Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers. J Cell Sci (1990) 0.94
Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res (1998) 0.93
Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. Int J Pharm (2001) 0.93
Optical inspection of punches: flat surfaces. Eur J Pharm Biopharm (2000) 0.93
Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier. Histochem Cell Biol (2001) 0.92
Cerebrovascular Biology and the various neural barriers: challenges and future directions. Neurosurgery (1999) 0.91
Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int J Immunopharmacol (1995) 0.90
Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci (1999) 0.90
Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release (1999) 0.90
Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J Drug Target (1994) 0.90
Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Curr Eye Res (1995) 0.89
A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR). Pharm Res (2001) 0.89
Oligonucleotide-cationic liposome interactions. A physicochemical study. Biochim Biophys Acta (1994) 0.89
Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. J Pharm Pharmacol (1996) 0.89
Regeneration and maintenance of bile canalicular networks in collagen-sandwiched hepatocytes. Toxicol In Vitro (2000) 0.88
A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides. Eur J Pharm Sci (2000) 0.87
Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. Life Sci (1998) 0.87
Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line. Int J Pharm (2000) 0.86
Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sci (1996) 0.86
Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits. J Lab Clin Med (1996) 0.86
Dynamic solid-state and tableting properties of four theophylline forms. Int J Pharm (2001) 0.85
Thermodynamic group contributions for hydroxyl, amino, and methylene groups. J Pharm Sci (1978) 0.85
Determination of thermodynamics of the methylene group in solutions of drug molecules. J Pharm Pharmacol (1972) 0.85
Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol (2000) 0.85
Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine. Invest Ophthalmol Vis Sci (1990) 0.84
Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochim Biophys Acta (1994) 0.83
Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm Res (1990) 0.83
Investigation of the metabolism of substance P at the blood-brain barrier using capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis (2001) 0.83
Changes in brain microvessel endothelial cell monolayer permeability induced by adrenergic drugs. Eur J Pharmacol (1994) 0.83
Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium. Brain Res (1999) 0.83
Solubility determination of barely aqueous-soluble organic solids. J Pharm Sci (1979) 0.83
In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy. Acta Pharm Nord (1990) 0.83
A comparison between iris-ciliary body concentration and receptor affinity of timolol. Acta Ophthalmol (Copenh) (1985) 0.83
Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells. Adv Pharmacol (1991) 0.83
Roles of acid/base nature and molecular weight in drug release from matrices of gelfoam and monoisopropyl ester of poly(vinyl methyl ether-maleic anhydride). J Control Release (1998) 0.83
Formation of permeability barrier in epidermal organotypic culture for studies on drug transport. J Invest Dermatol (2001) 0.82
Bioavailability of doxycycline from dissolved doxycycline hydrochloride tablets--comparison to solid form hydrochloride tablets and dissolved monohydrate tablets. Int J Clin Pharmacol Ther Toxicol (1990) 0.82
Level A in vitro-in vivo correlation (IVIVC) model with Bayesian approach to formulation series. J Pharm Sci (2006) 0.82
Controlled transdermal iontophoresis by ion-exchange fiber. J Control Release (2000) 0.82
Compressional characteristics of four starches. J Pharm Pharmacol (1983) 0.82
Predicting plasticization efficiency from three-dimensional molecular structure of a polymer plasticizer. Pharm Res (2001) 0.82
Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation. Eur J Pharm Sci (2000) 0.82
The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm Res (1989) 0.82
Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary culture. Pharm Res (1988) 0.81
21-aminosteroid and 2-(aminomethyl)chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radic Biol Med (1995) 0.81
Enhanced rectal absortion of insulin and heparin in rats in the presence of non-surfactant adjuvants. J Pharm Pharmacol (1981) 0.81
Enhanced rectal absorption of cefmetazole and cefoxitin in the presence of epinephrine metabolites in rats and a high-performance liquid chromatographic assay for cephamycin antibiotics. J Pharm Sci (1984) 0.81
Unsaturated cyclic ureas as new nontoxic biodegradable transdermal penetration enhancers I: Synthesis. J Pharm Sci (1988) 0.81
Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties. Bioconjug Chem (1999) 0.81
Enhanced rectal absorption of theophylline, lidocaine, cefmetazole, and levodopa by several adjuvants. J Pharm Sci (1982) 0.81
In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres. J Microencapsul (1997) 0.81
Angiotensin peptide regulation of fluid-phase endocytosis in brain microvessel endothelial cell monolayers. J Cereb Blood Flow Metab (1990) 0.81
Comparison of the effects of sodium salicylate, disodium ethylenediaminetetraacetic acid and polyoxyethylene-23-lauryl ether as adjuvants for the rectal absorption of sodium cefoxitin. J Pharm Pharmacol (1985) 0.81
Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther (1999) 0.81
Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200 mg preparations. Int J Clin Pharmacol Ther Toxicol (1990) 0.81
Pharmacokinetics in rat of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a drinking water mutagen, after a single dose. Pharmacol Toxicol (1992) 0.81
Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells. Neurochem Res (1998) 0.81
Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta (2005) 0.80
Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers. J Neurochem (1986) 0.80
Fatty acid transport regulatory proteins in the developing rat placenta and in trophoblast cell culture models. Placenta (2000) 0.80
Effects of salicylate on rectal absorption of theophylline. J Pharm Sci (1981) 0.80
Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery. Biochim Biophys Acta (2000) 0.80
Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide. Life Sci (1996) 0.80
Effect of salicylate on the rectal absorption of lidocaine, levodopa, and cefmetazole in rats. J Pharm Sci (1982) 0.80